tocilizumab has more serious side effects than leronlimab, almost certainly. And is not likely to prove as effective. BUT, unlike sarilumab, it has shown effectiveness in trials abroad. AND there are tocilizumab trials scheduled in the US, while the sarilumab trials failed. That author missed the two most obvious mabs on the map while including three that are not is bad journalism (which CNN is famous for).